Summit Financial LLC decreased its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 6.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,142 shares of the biopharmaceutical company’s stock after selling 1,057 shares during the period. Summit Financial LLC’s holdings […]
Pfizer Inc. (NYSE:PFE – Free Report) – Equities research analysts at Leerink Partnrs boosted their FY2025 earnings per share (EPS) estimates for Pfizer in a research report issued to clients and investors on Thursday, May 2nd. Leerink Partnrs analyst D. Risinger now forecasts that the biopharmaceutical company will post earnings per share of $2.93 for […]
Norden Group LLC lowered its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 9.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,932 shares of the biopharmaceutical company’s stock after selling 2,535 shares during the period. Norden Group […]
Wedgewood Investors Inc. PA lowered its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 6.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,622 shares of the biopharmaceutical company’s stock after selling 921 shares during the period. Wedgewood Investors Inc. PA’s holdings in Pfizer were […]
Norden Group LLC lowered its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 9.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 23,932 shares of the biopharmaceutical company’s stock after selling 2,535 shares during the quarter. Norden Group LLC’s holdings […]